344 related articles for article (PubMed ID: 15585990)
1. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations.
Sueda S; Kohno H; Fukuda H; Ochi N; Kawada H; Hayashi Y; Uraoka T
Coron Artery Dis; 2004 Dec; 15(8):491-7. PubMed ID: 15585990
[TBL] [Abstract][Full Text] [Related]
2. Induction of coronary artery spasm by two pharmacological agents: comparison between intracoronary injection of acetylcholine and ergonovine.
Sueda S; Kohno H; Fukuda H; Ochi N; Kawada H; Hayashi Y; Uraoka T
Coron Artery Dis; 2003 Sep; 14(6):451-7. PubMed ID: 12966266
[TBL] [Abstract][Full Text] [Related]
3. Differential incidence and morphology of provoked spasm between intracoronary acetylcholine and ergonovine testing: recommendation of supplementary use.
Sueda S; Fujimoto K; Sasaki Y; Sakaue T; Yoshii T; Habara H; Kohno H
Heart Vessels; 2019 May; 34(5):745-754. PubMed ID: 30474702
[TBL] [Abstract][Full Text] [Related]
4. New combined spasm provocation test in patients with rest angina: intracoronary injection of acetylcholine after intracoronary administration of ergonovine.
Sueda S; Ochi T; Yano K; Mineoi K; Kondou T; Ochi N; Hayashi Y; Kukita H; Matsuda S; Kawada H; Tsuruoka T; Uraoka T
Jpn Circ J; 2000 Aug; 64(8):559-65. PubMed ID: 10952150
[TBL] [Abstract][Full Text] [Related]
5. Safety and optimal protocol of provocation test for diagnosis of multivessel coronary spasm.
Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
Heart Vessels; 2016 Feb; 31(2):137-42. PubMed ID: 25366987
[TBL] [Abstract][Full Text] [Related]
6. Sequential spasm provocation tests might overcome a limitation of the standard spasm provocation tests.
Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
Coron Artery Dis; 2015 Sep; 26(6):490-4. PubMed ID: 25974266
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in sensitivity of acetylcholine and ergonovine to coronary spasm provocation test.
Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
Heart Vessels; 2016 Mar; 31(3):322-9. PubMed ID: 25539623
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological spasm provocation testing in 2500 patients: provoked spasm incidence, complications and cardiac events.
Sueda S
Heart Vessels; 2020 Oct; 35(10):1368-1377. PubMed ID: 32350639
[TBL] [Abstract][Full Text] [Related]
9. Safety and potential usefulness of sequential intracoronary acetylcholine and ergonovine administration for spasm provocation testing.
Kinoshita Y; Saito Y; Kikuta Y; Sato K; Taniguchi M; Goto K; Takebayashi H; Haruta S; Kobayashi Y
Ther Adv Cardiovasc Dis; 2024; 18():17539447241233168. PubMed ID: 38396350
[TBL] [Abstract][Full Text] [Related]
10. Frequency of provoked coronary spasms in patients undergoing coronary arteriography using a spasm provocation test via intracoronary administration of ergonovine.
Sueda S; Kohno H; Fukuda H; Ochi N; Kawada H; Hayashi Y; Uraoka T
Angiology; 2004; 55(4):403-11. PubMed ID: 15258686
[TBL] [Abstract][Full Text] [Related]
11. Clinical and angiographical characteristics of acetylcholine- induced spasm: relationship to dose of intracoronary injection of acetylcholine.
Sueda S; Kohno H; Fukuda H; Inoue K; Suzuki J; Watanabe K; Ochi T; Uraoka T
Coron Artery Dis; 2002 Jun; 13(4):231-6. PubMed ID: 12193850
[TBL] [Abstract][Full Text] [Related]
12. Differential Incidence and Morphology of Spasm According to Coronary Arterial Location by Intracoronary Ergonovine Spasm Provocation Testing.
Sueda S; Kohno H
Circ J; 2017 May; 81(6):831-836. PubMed ID: 28331112
[TBL] [Abstract][Full Text] [Related]
13. Increased basal tone and hyperresponsiveness to acetylcholine and ergonovine in spasm related coronary arteries in patients with variant angina--basal coronary artery tone in patients with variant angina.
Park SJ; Park SW; Kim JJ; Song JK; Hong MK; Kang DH; Cheong SS; Lee CW; Lee JK
J Korean Med Sci; 1996 Feb; 11(1):17-25. PubMed ID: 8703366
[TBL] [Abstract][Full Text] [Related]
14. Intracoronary administration of a thromboxane A2 synthase inhibitor relieves acetylcholine-induced coronary spasm.
Sueda S; Kohno H; Inoue K; Fukuda H; Suzuki J; Watanabe K; Ochi N; Kawada H; Uraoka T
Circ J; 2002 Sep; 66(9):826-30. PubMed ID: 12224820
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of omitting provocation test with 50 μg of acetylcholine in left coronary artery.
Saito Y; Kitahara H; Shoji T; Tokimasa S; Nakayama T; Sugimoto K; Fujimoto Y; Kobayashi Y
Heart Vessels; 2017 Jun; 32(6):685-689. PubMed ID: 27873006
[TBL] [Abstract][Full Text] [Related]
16. The acetylcholine administration time plays the key role for provoked spasm in the spasm provocation test.
Sueda S; Kohno H
J Cardiol; 2017 Aug; 70(2):141-146. PubMed ID: 27988074
[TBL] [Abstract][Full Text] [Related]
17. One of six patients with non-ischemic heart disease exhibit provoked coronary spasms: non-ischemic heart disease associated with ischemia?
Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
Intern Med; 2015; 54(3):281-6. PubMed ID: 25748736
[TBL] [Abstract][Full Text] [Related]
18. Overview of complications during pharmacological spasm provocation tests.
Sueda S; Kohno H
J Cardiol; 2016 Jul; 68(1):1-6. PubMed ID: 27234219
[TBL] [Abstract][Full Text] [Related]
19. Bronchial Asthma and Rest Angina: Is It Safe to Perform Acetylcholine Spasm Provocation Tests in These Patients?
Sueda S
Intern Med; 2020 Dec; 59(24):3117-3122. PubMed ID: 32788543
[TBL] [Abstract][Full Text] [Related]
20. Differential incidence and type of spasm according to coronary arterial location.
Sueda S; Kohno H
Coron Artery Dis; 2016 Jun; 27(4):273-6. PubMed ID: 26901444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
